Johnson & Johnson
(JNJ)Financial Overview
About Johnson & Johnson
Johnson & Johnson, led by CEO Joaquin Duato, is a global healthcare conglomerate operating across pharmaceuticals, medical devices, and consumer health products. The company is known for brands like Tylenol, Band-Aid, and recently spun off its consumer division as Kenvue. J&J has been instrumental in producing vaccines and therapies, including its single-dose COVID-19 vaccine. It continues to invest in oncology, immunology, and robotic surgery through its MedTech division. The company remains a cornerstone in healthcare innovation and one of the most valuable in the sector.
Analyst Forecast
Johnson & Johnson continues to evolve following the Kenvue spinoff, focusing its core on high-margin pharmaceuticals and MedTech. Its drug pipeline is competitive, particularly in oncology and immunology. Medical devices are seeing renewed growth post-pandemic as elective procedures normalize. Legal liabilities, especially in talc litigation, remain an overhang but are declining. J&J’s AAA credit rating and dividend aristocrat status make it a reliable anchor. A conservative choice with steady upside.
Analysis by John Glover
Senior Financial Analyst
Experienced financial analyst specializing in company ratings and sector performance. Delivers in-depth evaluations of financial health, growth potential, and risk exposure to support investment decisions. Skilled in ratio analysis, forecasting, and market benchmarking.
9 years of experience
Should You Buy Johnson & Johnson Stock?
This interactive tool helps you determine whether this stock fits into your investment strategy based on your portfolio size, risk tolerance, and allocation preferences.
What this calculator analyzes:
- Risk compatibility between your profile and this stock
- Appropriate allocation size for your portfolio
- Diversification recommendations
- P/E ratio context and valuation analysis
Example Analysis:
A 22.9 P/E ratio indicates this stock has a moderate valuation. With a Low risk rating, this stock may be suitable for conservative portfolios.
⚠️ This tool is for informational purposes only. It does not constitute financial advice. Investing involves risk, including loss of capital. Always consult a licensed financial advisor before making investment decisions.